ANGN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jun 2023 @ 22:00):

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases...

Stats
Dagens volum	224 803
Gjennomsnittsvolum	9 772.00
Markedsverdi	30.11M
EPS	$0 ( 2024-03-15 )
Neste inntjeningsdato	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0989
ATR14	$0.0950 (9.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Nissenson Allen	Buy	4 100	Stock Option (right to buy)
2023-12-28	Chudnovsky Yekaterina	Buy	4 100	Stock Option (right to buy)
2023-12-28	Wilson Karen J	Buy	4 100	Stock Option (right to buy)
2023-12-28	Adams Julian	Buy	4 100	Stock Option (right to buy)
2023-12-28	Venkatesan Jay	Buy	4 100	Stock Option (right to buy)

INSIDER POWER
56.58
Last 97 transactions
Buy: 4 979 407 \| Sell: 2 616 033

Volum Korrelasjon

Lang: 0.38 (neutral)

Kort: 0.32 (neutral)

Signal:(71.808) Neutral

Angion Biomedica Corp. Korrelasjon

10 Mest positive korrelasjoner
MYSZ	0.924
SMFL	0.92
ALXO	0.915
IRBT	0.914
SSPK	0.913
TRIT	0.908
SPCX	0.905
VNDA	0.903
NCBS	0.903
MTP	0.902

10 Mest negative korrelasjoner
CFFE	-0.929
ARIZ	-0.924
LRMR	-0.922
ROCL	-0.922
OTEC	-0.919
FICV	-0.916
OVLY	-0.915
AIB	-0.914
FATP	-0.914
EMLD	-0.914

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Angion Biomedica Corp. Korrelasjon - Valuta/Råvare

-0.37
( neutral )

0.16
( neutral )

0.00
( neutral )

-0.42
( neutral )

-0.40
( neutral )

-0.46
( neutral )

Angion Biomedica Corp. Økonomi

Annual	2022
Omsetning:	$2.30M
Bruttogevinst:	$2.30M (100.00 %)
EPS:	$-1.850

FY	2022
Omsetning:	$2.30M
Bruttogevinst:	$2.30M (100.00 %)
EPS:	$-1.850

FY	2021
Omsetning:	$28.31M
Bruttogevinst:	$27.88M (98.47 %)
EPS:	$-1.930

FY	2020
Omsetning:	$2.88M
Bruttogevinst:	$1.69M (58.68 %)
EPS:	$-2.78

Financial Reports:

No articles found.

Angion Biomedica Corp.

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Sanntidsoppdatering for Angion Biomedica Corp. [ANGN]

Upcoming Earnings Alert